Flexion Therapeutics to Report Second-Quarter 2021 Financial Results on August 4, 2021
July 29 2021 - 4:15PM
Flexion Therapeutics, Inc. (Nasdaq:FLXN) today announced that it
will report its second-quarter 2021 financial results after the
close of the U.S. financial markets on Wednesday, August 4, 2021 at
4:30 p.m. ET.
A live webcast of the conference call can be
accessed through the “Investors” tab on the Flexion Therapeutics
website, and a replay will be available online after the call. For
those planning to ask a question, the dial-in number for the
conference call is 855-770-0022 for domestic participants and
908-982-4677 for international participants, with Conference ID #
3846257. Please dial in at least 15 minutes in advance to ensure a
timely connection to the call.
About Flexion TherapeuticsFlexion
Therapeutics (Nasdaq:FLXN) is a biopharmaceutical company
focused on the development and commercialization of novel, local
therapies for the treatment of patients with musculoskeletal
conditions, beginning with osteoarthritis, the most common form of
arthritis. The company's core values are focus, ingenuity,
tenacity, transparency and fun. Please visit
flexiontherapeutics.com.
Contact:
Scott YoungVice President, Corporate Communications
& Investor RelationsT:
781-305-7194syoung@flexiontherapeutics.com
Flexion Therapeutics (NASDAQ:FLXN)
Historical Stock Chart
From Aug 2024 to Sep 2024
Flexion Therapeutics (NASDAQ:FLXN)
Historical Stock Chart
From Sep 2023 to Sep 2024